Indietro

Selezionare la regione

Azienda

Richiedi un consulto sulle cellule staminali

Per saperne di più

I nostri
trapianti

Elenco degli utilizzi delle cellule staminali approvati dai laboratori del gruppo FamiCord:

Immagine
Elenco degli utilizzi delle cellule staminali approvati dai laboratori del gruppo FamiCord:
Nr. Fonte Tipo di fonte Diagnosi Settore medico Anno di applicazione Terapia Paese Età del destinatario
901 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 6
902 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 44
903 Bone Marrow Allogeneic Paroxysmal Nocturnal Hemoglobinuria Hematology 2025 Standard Therapy Poland 25
904 Bone Marrow Allogeneic Juvenile Myelomonocytic Leukemia Hematology 2025 Standard Therapy Poland 4
905 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy USA 21
906 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Italy 12
907 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Hungary 10
908 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Czechia 68
909 Bone Marrow Allogeneic Adrenoleukodystrophy Hematology 2025 Standard Therapy Poland 53
910 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Germany 4
911 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy France 4
912 Bone Marrow Allogeneic Paroxysmal Nocturnal Hemoglobinuria Hematology 2025 Standard Therapy Norway 18
913 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Spain 24
914 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Belarus 5
915 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Germany 53
916 Bone Marrow Allogeneic diamond-Balckfan anemia Hematology 2025 Standard Therapy Germany 11
917 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 57
918 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 61
919 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy France 3
920 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Belarus 1
921 Bone Marrow Allogeneic pB-Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Germany 15
922 Bone Marrow Allogeneic OHID XIAP – Other Histiocytic Disorders / X-Linked Inhibitor of Apoptosis Protein Hematology 2025 Standard Therapy Switzerland 2
923 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 46
924 Bone Marrow Allogeneic Acquired Idiopathic Sideroblastic Anemia Hematology 2025 Standard Therapy Russian Federation 5
925 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 10
926 Bone Marrow Allogeneic Hodgkin Lymphoma Hematology 2025 Standard Therapy USA 47
927 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy CROATIA 11
928 Bone Marrow Allogeneic Juvenile myelomonocytic leukemia Hematology 2025 Standard Therapy Poland 5
929 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Brazil 12
930 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Australia 8
931 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 3
932 Bone Marrow Allogeneic Myelodysplatic Syndrome Hematology 2025 Standard Therapy USA 60
933 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Russia 36
934 Bone Marrow Allogeneic Thalassemia major Hematology 2025 Standard Therapy Turkey 10
935 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 58
936 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 2
937 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy USA 18
938 Bone Marrow Allogeneic Other Non-Malignant Disease, Specify Hematology 2025 Standard Therapy USA 17
939 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 15
940 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 15
941 Bone Marrow Allogeneic aplastic anemia Hematology 2025 Standard Therapy Belgium 36
942 Bone Marrow Allogeneic Primary Refractory Hematology 2025 Standard Therapy Ireland 27
943 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 39
944 Bone Marrow Allogeneic Sickle Cell Disease (SCD) Hematology 2025 Standard Therapy Italy 8
945 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 68
946 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy USA 58
947 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 1
948 Bone Marrow Allogeneic Severe Combined Immunodeficiency Hematology 2025 Standard Therapy United Kingdom 13
949 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Denmark 38
950 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 17
951 Bone Marrow Allogeneic Fanconi Anemia Hematology 2025 Standard Therapy Poland 11
952 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 9
953 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy USA 3
954 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy France 9
955 Bone Marrow Allogeneic Fanconi Anemia  Hematology 2025 Standard Therapy Poland 8
956 Bone Marrow Allogeneic Immune Deficiency Hematology 2025 Standard Therapy United Kingdom 10
957 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Germany 12
958 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy USA 20
959 Bone Marrow Allogeneic Hodgkin Lymphoma Hematology 2025 Standard Therapy Turkey 17
960 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 13
961 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Canada 22
962 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 15
963 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Italy 8
964 Bone Marrow Allogeneic Inherited Immune System Disorder Hematology 2025 Standard Therapy France 3
965 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Italy 2
966 Bone Marrow Allogeneic Bone Marrow Failure Hematology 2025 Standard Therapy Netherlands 23
967 Bone Marrow Allogeneic Chronic Granulomatous Disease Hematology 2025 Standard Therapy Italy 6
968 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 5
969 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 58
970 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 34
971 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 61
972 Apheresis Allogeneic Myelodysplastic Syndrome/Myeloproliferative neoplasm Hematology 2025 Standard Therapy NETHERLANDS 62
973 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Austria 68
974 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 70
975 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 66
976 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 77
977 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Ukraine 12
978 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 58
979 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 67
980 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 4
981 Apheresis Allogeneic Myelofibrosis Myeloid Metaplasia Hematology 2025 Standard Therapy USA 73
982 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 56
983 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Italy 50
984 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 39
985 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Lithuania 43
986 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2025 Standard Therapy Poland 66
987 Apheresis Allogeneic Multiple Myeloma Hematology 2025 Standard Therapy USA 61
988 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Austria 55
989 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 69
990 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Denmark 67
991 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy United Kingdom 75
992 Apheresis Allogeneic T – cell Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 24
993 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Belgium 68
994 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Ukraine 42
995 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy USA 50
996 Apheresis Allogeneic Prolymphocytic Leukemia Hematology 2025 Standard Therapy USA 62
997 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy United Kingdom 62
998 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2025 Standard Therapy USA 69
999 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 85
1000 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 54